Insider filing
Traded Nov 9 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 13, 2026 · Filed Nov 16, 2026
The CFO of Immuneering paid $90K out of pocket for Immuneering shares. It was the first purchase in over a year. Shares held went up 11% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$89,500
Shares × reported transaction price
$25K–$100K
+11.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 17 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
15 days after results of Oct 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $3.71 on Nov 13, 2026, 10% above its 52-week low and 55% below its high, after a 9% drop over the previous 30 trading days
52-week range $3.37 (Nov 5, 2026) to $8.33 (Jan 7, 2026), 7% of the way up, from 250 adjusted closes. 30 trading days earlier: $4.07 on Oct 2, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Andrew Gengos's first open-market purchase of IMRX in filings since 2021
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 9 · filed the same day
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.